STERIS PLC (STE) Stock Price, Forecast & Analysis
NYSE:STE • IE00BFY8C754
STE Key Statistics, Chart & Performance
The current stock price of STE is 246.75 USD. In the past month the price decreased by -7.58%. In the past year, price increased by 11.34%.
STE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to STE. When comparing the yearly performance of all stocks, STE turns out to be only a medium performer in the overall market: it outperformed 49.94% of all stocks.
STE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to STE. STE scores excellent on profitability, but there are some minor concerns on its financial health.
STE Financial Highlights
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 10.08. The EPS increased by 9.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.15% | ||
| ROA | 6.68% | ||
| ROE | 9.88% | ||
| Debt/Equity | 0.26 |
STE Forecast & Estimates
14 analysts have analysed STE and the average price target is 287.85 USD. This implies a price increase of 16.65% is expected in the next year compared to the current price of 246.75.
For the next year, analysts expect an EPS growth of 10.36% and a revenue growth 8.72% for STE
STE Ownership
STE Latest News, Press Relases and Analysis
STE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.51 | 193.832B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.93 | 169.664B | ||
| SYK | STRYKER CORP | 24.56 | 139.908B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.43 | 109.921B | ||
| BDX | BECTON DICKINSON AND CO | 11.26 | 50.66B | ||
| IDXX | IDEXX LABORATORIES INC | 42.62 | 49.283B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.81 | 44.358B | ||
| RMD | RESMED INC | 20.58 | 35.869B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 35.845B | ||
| DXCM | DEXCOM INC | 28.04 | 25.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STE
Company Profile
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Company Info
STERIS PLC
70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 17787
Phone: 35312322000
STERIS PLC / STE FAQ
Can you describe the business of STERIS PLC?
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
What is the stock price of STERIS PLC today?
The current stock price of STE is 246.75 USD. The price increased by 1.04% in the last trading session.
Does STERIS PLC pay dividends?
STERIS PLC (STE) has a dividend yield of 1.04%. The yearly dividend amount is currently 2.23.
What is the ChartMill technical and fundamental rating of STE stock?
STE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
On which exchange is STE stock listed?
STE stock is listed on the New York Stock Exchange exchange.
What is the ex-dividend date for STE stock?
The next ex-dividend date for STERIS PLC (STE) is February 17, 2026.
Who owns STERIS PLC?
You can find the ownership structure of STERIS PLC (STE) on the Ownership tab.